HEALTH

FDA approves generic OTC allergy medication

BY Alaric DeArment

ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of an OTC allergy drug, FDA records show.

The agency approved Anmeal Pharmaceuticals’ cetirizine hydrochloride syrup in the 5 mg-per-5 milliliter strength.

The drug is a generic version of Johnson & Johnson’s Zyrtec. Amneal is the 10th company to gain FDA approval for a generic version of the drug. J&J switched Zyrtec from a prescription to an OTC drug last year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

New research finds link between antioxidants, increased diabetes risk

BY Michael Johnsen

ST. LOUIS A new report in the Oct. 7 issue of Cell Metabolism, a Cell Press publication, found that low levels of free radicals – which commonly are perceived as damaging to a body and the reason behind the consumption of antioxidant vitamins – might actually prevent diabetes by improving the ability to respond to insulin signals.

“Our studies indicate that ‘physiological’ low levels of [free radicals] may promote the insulin response and attenuate insulin resistance early in the progression of Type 2 diabetes, prior to overt obesity and hyperglycemia,” stated Tony Tiganis of Monash University in Australia.

Tiganis said whether antioxidants ultimately are good for people probably will depend on their state of health or disease. “In the case of early Type 2 diabetes and the development of insulin resistance, our studies suggest that antioxidants would be bad for you,” he said.

Under some conditions, treatments designed to selectively increase ROS in muscle – if they can be devised – might even help, he said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Florastor products to be sold at CVS/pharmacy

BY Michael Johnsen

SAN BRUNO, Calif. As part of its continued expansion throughout the U.S. retail market, Biocodex, the U.S. distributor of Florastor and Florastor Kids, has secured distribution through CVS/pharmacy beginning this month, the company announced. Florastor will be placed on-shelf in the stomach/digestives aisle, while Florastor Kids will be available upon request behind the counter.

According to Dan Harper, director of sales for Biocodex, the stomach/digestives aisle is the most appropriate spot for this product – in the company of popular anti-diarrheal remedies.

“While Florastor is technically a dietary supplement, it is used successfully by many to manage digestive ailments and diarrhea, so it makes sense for it to be available in the section where the consumer will be looking for those types of items,” Harper said.

“When Florastor was first introduced to Americans, the idea of probiotics was not well understood by mainstream consumers or even traditional medical practitioners,” stated Marc Rohman, U.S. VP and GM of Biocodex. “However, as Americans are becoming increasingly aware of the benefits of probiotics, particularly yeast-based probiotics such as Florastor, expanding distribution into the chain stores was the next logical step to meet the demand we’re seeing.”

According to Rohman, sales of Florastor have grown annually, even without widespread on-shelf availability, as a result of increased pharmacist and consumer awareness of the probiotic category, word-of-mouth and physician recommendations.

The latest chain shelf space acquisitions are the result of Biocodex’s work with Morgan & Sampson USA, with which Biocodex teamed to help manage its growth and distribution within the U.S. retail trade.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?